Home » Stocks » BioLife Solutions

BioLife Solutions, Inc. (BLFS)

Stock Price: $28.71 USD -0.31 (-1.07%)
Updated Oct 26, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 931.44M
Revenue (ttm) 36.98M
Net Income (ttm) -938,000
Shares Out 32.44M
EPS (ttm) 0.58
PE Ratio 49.50
Forward PE 416.67
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 26, 2020
Last Price $28.71
Previous Close $29.02
Change ($) -0.31
Change (%) -1.07%
Day's Open 28.65
Day's Range 27.86 - 29.26
Day's Volume 218,980
52-Week Range 7.37 - 30.27

More Stats

Market Cap 931.44M
Enterprise Value 902.52M
Earnings Date (est) Nov 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 32.44M
Float 25.25M
EPS (basic) n/a
EPS (diluted) 0.58
FCF / Share 0.06
Dividend n/a
Dividend Yield n/a
Earnings Yield 2.02%
FCF Yield 0.14%
Payout Ratio n/a
Shares Short 1.72M
Short Ratio 4.00
Short % of Float 6.79%
Beta 1.44
PE Ratio 49.50
Forward PE 416.67
P/FCF Ratio 728.83
PS Ratio 25.19
PB Ratio 8.76
Revenue 36.98M
Operating Income -2.69M
Net Income -938,000
Free Cash Flow 1.28M
Net Cash 28.92M
Net Cash / Share 0.89
Gross Margin 51.11%
Operating Margin -7.28%
Profit Margin -2.50%
FCF Margin 3.46%
ROA -0.75%
ROE 25.22%
ROIC -13.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (8)

Buy 6
Overweight 0
Hold 2
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$32.21*
(12.19% upside)
Low
21.0
Current: $28.71
High
35.5
Target: 32.21
*Average 12-month price target from 7 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue27.3719.7411.028.236.456.198.955.662.762.08
Revenue Growth38.64%79.11%33.97%27.57%4.17%-30.83%58.03%105.28%32.53%-
Gross Profit18.6113.536.754.783.813.043.762.291.400.86
Operating Income-0.173.66-1.06-4.85-5.02-3.14-0.29-0.94-1.21-1.39
Net Income-1.66-25.01-2.52-6.88-4.21-3.22-1.08-1.66-1.96-1.98
Shares Outstanding19.4616.2613.2612.6412.1810.455.014.984.984.98
Earnings Per Share-0.09-1.56-0.21-0.54-0.35-0.31-0.22-0.33-0.42-0.42
Operating Cash Flow1.212.350.61-4.33-4.97-3.160.150.85-0.99-1.25
Capital Expenditures-2.33-0.50-0.14-1.26-1.42-0.59-0.24-1.15-0.09-0.03
Free Cash Flow-1.121.850.46-5.58-6.39-3.75-0.09-0.30-1.08-1.28
Cash & Equivalents6.4530.666.661.413.829.940.160.200.020.00
Total Debt1.35--2.84--10.6010.6010.139.03
Net Cash / Debt5.0930.666.66-1.443.829.94-10.45-10.41-10.11-9.03
Assets92.8245.4712.147.9312.3716.073.353.171.661.31
Liabilities49.3630.842.054.762.512.1416.6215.6612.8410.86
Book Value43.4514.6310.093.178.5111.80-13.27-12.49-11.18-9.55
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name BioLife Solutions, Inc.
Country United States
CEO Michael P. Rice

Stock Information

Ticker Symbol BLFS
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NASDAQ: BLFS
IPO Date November 22, 1989

Description

BioLife Solutions develops, manufactures, and supplies bioproduction tools for the cell and gene therapy industry in North America, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; and liquid nitrogen laboratory freezers, cryogenic equipment, and accessories. The company markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was founded in 1987 and is headquartered in Bothell, Washington.